French National Agency For Research On Aids And Viral Hepatitis
Clinical trials sponsored by French National Agency For Research On Aids And Viral Hepatitis, explained in plain language.
-
Hepatitis b drug combo trial halted early – hope for virus control remains
Disease control TerminatedThis study compared two hepatitis B medications, clevudine and tenofovir, given alone or together for 96 weeks in adults with chronic hepatitis B who had not been treated before. The goal was to see if the combination could better control the virus and reduce the risk of it comin…
Phase: PHASE3 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Kaposi sarcoma drug trial halted early – what we learned
Disease control TerminatedThis study tested the drug lenalidomide in 12 people with HIV who had progressive Kaposi sarcoma. The goal was to see if the drug could shrink tumors while patients continued their HIV treatment. The trial was stopped early, but researchers still tracked safety and tumor response…
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated May 26, 2026 12:08 UTC